Author:
Aukema Tjeerd S.,Olmos Renato A. Valdés,Korse Catharina M.,Kroon Bin B. R.,Wouters Michel W. J. M.,Vogel Wouter V.,Bonfrer Johannes M. G.,Nieweg Omgo E.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Guo HB, Stoffel-Wagner B, Bierwirth T, Mezger J, Klingmuller D. Clinical significance of serum S100 in metastatic malignant melanoma. Eur J Cancer. 1995;31A:1898–902.
2. Banfalvi T, Gilde K, Gergye M, Boldizsar M, Kremmer T, Otto S. Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma. Eur J Cancer. 2003;39:164–9.
3. Smit LH, Korse CM, Hart AA, Bonfrer JM, Haanen JB, Kerst JM, et al. Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients. Eur J Cancer. 2005;41:386–92.
4. Tarhini AA, Stuckert J, Lee S, Sander C, Kirkwood JM. Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694. J Clin Oncol. 2009;27:38–44.
5. Smit LH, Nieweg OE, Mooi WJ, Bonfrer JM, Haanen JB, Kroon BB, et al. Value of serum S-100B for prediction of distant relapse and survival in stage III B/C melanoma. Anticancer Res. 2008;28:2297–302.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献